Home > Books > Myeloma: Emerging Cancer Therapeutics
Myeloma: Emerging Cancer Therapeutics
View PDF

Myeloma: Emerging Cancer Therapeutics

Publication Year: 2010
Edition: 1st
Authors/Editor: Kumar
Publisher: Springer Publishing Company
ISBN: 978-1-933-86491-4
Doody's Star Rating®:  Score: 73
  • Description
  • Details

This volume reviews the current literature, provides critical evaluations of the data and offers evidence-based recommendations.

It is estimated that over 20,000 new cases are diagnosed each year with over 10,000 people dying from these malignancies. Multiple myelomas are highly treatable but rarely curable. Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their management.

Management options and outcomes for individuals with multiple myelomas improved dramatically with the introduction of chemotherapy. Even further improvements in prognosis have occurred because of the introduction of newer therapies such as pulse corticosteroids, thalidomide, bortezomib, and autologous and allogeneic stem cell transplantation. With the increased number of therapeutic options to choose from, the clinician is better placed to offer effective therapy but at the same time is challenged to keep abreast of the rapidly changing treatment landscape and the newly emerging data that is shaping the treatment options today and in the future. Multiple Myeloma provides a comprehensive and in-depth review of this group of malignancies.

About the Series:
Emerging Cancer Therapeutics is an invited review publication providing a through analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence, current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and hematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging.

  • Platform:
    Ovid
  • Publisher: Springer Publishing Company
  • Product Type: Book
  • Author/Editor: Kumar
  • ISBN: 978-1-933-86491-4
  • Specialty:
    Hematology
    Oncology
    Radiology
    Surgery
  • Language: English
  • Edition: 1st
  • Pages: 200
  • Illustrations: 0
  • Year: 2010
  • Doody's Star Rating®:  Score: 73

Free Instant Access
This Month

JOTM
Biomedical Research Grants—UberResearch NEW! UberResearch is a searchable database of awarded research funding that includes more than 600,000 indexed records. And now it's available on the Ovid® platform!
JOTM
The Philosopher's Index The Philosopher's Index is a bibliographic database with informative author-written abstracts covering scholarly research in the fifteen fields of philosophy, published in journals and books since 1940.
JOTM
Evidence-Based Practice Evidence-Based Practice is a quarterly journal focused on topics relevant to the daily practice of family medicine and includes content addressing timely and pertinent questions related to patient care.
JOTM
Stroke An official journal of the American Heart Association, Stroke publishes reports of clinical and basic investigation of any aspect of the cerebral circulation and its diseases from many disciplines.

Noteworthy

Doody's Featured Books
Shields' General Thoracic Surgery, 8th Edition
Your #1 resource for comprehensive coverage of both open and endoscopic surgical techniques, with commentary from more than 150 global experts in the field.

The Washington Manual of Echocardiography, 2nd Edition
Essential information you need to successfully perform and read echocardiograms, as well as to identify valvular heart disease, cardiac myopathies, and congenital anomalies.